Showing results (211-220 of 363) with videos related to
Sort By:
Pageof 37
BJU International|June 8, 2007
A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trialPeter C Black, Karen Basen-Engquist, Xuemei Wang, et al.European Urology|October 1, 2018
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018Marcus George Kwesi Cumberbatch, Ibrahim Jubber, Peter C Black, et al.European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.Oncotarget|May 26, 2016
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinSimone Buraschi, Shi-Qiong Xu, Manuela Stefanello, et al.The Journal of Urology|February 20, 2020
A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Up StagingJoep J de Jong, Yang Liu, Stephen A Boorjian, et al.European Urology Oncology|October 14, 2023
Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)Laurence Klotz, Joseph Chin, Peter C Black, et al.IEEE Transactions on Medical Imaging|June 17, 2015
Statistical Biomechanical Surface Registration: Application to MR-TRUS Fusion for Prostate InterventionsSiavash Khallaghi, C Antonio Sánchez, Abtin Rasoulian, et al.Urologic Oncology|June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancerEdmund C P Chedgy, James Douglas, Jonathan L Wright, et al.NPJ Precision Oncology|July 3, 2026
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent mannerAymeric Zadoroznyj, Pontus Eriksson, Carina Bernardo, et al.Urologic Oncology|February 10, 2021
Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray projectGang Wang, Peter C Black, Peter J Goebell, et al.Pageof 37